(Reuters) – Rigel Pharmaceuticals said on Thursday the U.S. Food and Drug Administration has approved its drug for the treatment of patients with a type of leukemia.
(Reporting by Leroy Leo in Bengaluru; Editing by Maju Samuel)
U.S. FDA approves Rigel Pharma’s leukemia treatment
Dec 1, 2022 | 4:19 PM
